AM

Akhouri Maheshwar Prasad

Director Director DIN 07066439
DIN 07066439 First appointment Jan 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2015
Shareholding value •••• Premium profile

About Akhouri Maheshwar Prasad

Data last updated:

Akhouri Maheshwar Prasad was a Director at Indchemie Health Specialities Private Limited (2015–2025) and Director at Alkem Laboratories Limited (2015–2020). The companies operate in Pharma.

DIN 07066439
Primary Designation Director
Industry Pharma
First Appointment 30 Jan 2015

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Jul 20151986₹734 Cr (FY 2025)Active
Alkem Laboratories Limited L00305MH1973PLC174201
Director30 Jan 20151973₹15,296 Cr (FY 2026)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Indchemie Health Specialities Private Limited
Alkem Laboratories Limited
Premium access

Shareholding and investment profile for Akhouri Maheshwar Prasad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akhouri Maheshwar Prasad

Akhouri Maheshwar Prasad was first appointed on 30 Jan 2015 as Director at Alkem Laboratories Limited.

Akhouri Maheshwar Prasad held 2 earlier board appointments: Indchemie Health Specialities Private Limited (Director, 20 Jul 2015 to 19 Jul 2025); Alkem Laboratories Limited (Director, 30 Jan 2015 to 15 Mar 2020).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available